|
|
18F-FDG PET-CT肿瘤体积测量在胃癌分期中的应用
|
Abstract:
由于positron emission tomography-computed tomography (PET-CT)三维解剖的病灶体积测量，可以从各层面全方位测量有代谢活性的肿瘤组织的体积，肿瘤体积(Gross Tumor Volume, GTV)测量不受空腔脏器的蠕动、膨胀程度的影响，从而探讨胃癌体积测量与胃癌病理分期中的相关性及临床应用意义。因此PET-CT肿瘤体积测量在胃癌分期中有着前瞻性评估作用，可以为患者治疗方式提供依据。
Due to the positron emission tomography-computed tomography (PET-CT) three-dimensional ana-tomical focus volume measurement, the volume of metabolically active tumor tissue can be meas-ured from all levels, and the Gross Tumor Volume (GTV) measurement is not affected by the peri-stalsis and expansion of hollow organs to explore the correlation and clinical application signifi-cance of gastric cancer volume measurement and gastric cancer pathological staging. Therefore, PET-CT tumor volume measurement has a prospective evaluation role in gastric cancer staging, and can provide a basis for patient treatment.
| [1] | Smyth, E.C., Nilsson, M., Grabsch, H.I., van Grieken, N.C. and Lordick, F. (2020) Gastric Cancer. The Lancet, 396, 635-648. https://doi.org/10.1016/S0140-6736(20)31288-5 |
| [2] | Giganti, F., Orsenigo, E., Arcidiacono, P.G., Ni-coletti, R., Albarello, L., Ambrosi, A., Salerno, A., Esposito, A., Petrone, M.C., Chiari, D., Staudacher, C., Del Maschio, A. and De Cobelli, F. (2016) Preoperative Locoregional Staging of Gastric Cancer: Is There a Place for Magnetic Reso-nance Imaging? Prospective Comparison with EUS and Multidetector Computed Tomography. Gastric Cancer, 19, 216-225. |
| [3] | Basu, S., Hess, S., Nielsen Braad, P.E., Olsen, B.B., Inglev, S. and H？ilund-Carlsen, P.F. (2014) The Basic Principles of FDG-PET/CT Imaging. PET Clinics, 9, 355-370. https://doi.org/10.1016/j.cpet.2014.07.006 |
| [4] | Yun, M. (2014) Imaging of Gastric Cancer Metabolism Using 18F-FDG PET/CT. Journal of Gastric Cancer, 14, 1-6.
https://doi.org/10.5230/jgc.2014.14.1.1 |
| [5] | Smyth, E., Sch？der, H., Strong, V.E., Capanu, M., Kelsen, D.P., Coit, D.G. and Shah, M.A. (2012) A Prospective Evaluation of the Utility of 2-deoxy-2-[(18)F]fluoro-D-glucose Positron Emission Tomography and Computed Tomography in Staging Locally Advanced Gastric Cancer. Cancer, 118, 5481-5488. https://doi.org/10.1002/cncr.27550 |
| [6] | Kim, S.J., Cho, Y.S., Moon, S.H., Bae, J.M., Kim, S., Choe, Y.S., Kim, B.T. and Lee, K.H. (2016) Primary Tumor 18F-FDG Avidity Affects the Performance of 18F-FDG PET/CT for Detecting Gastric Cancer Recurrence. Journal of Nuclear Medicine, 57, 544-550. https://doi.org/10.2967/jnumed.115.163295 |
| [7] | In, H., Solsky, I., Palis, B., Langdon-Embry, M., Ajani, J. and Sano, T. (2017) Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer Using the National Cancer Database. Annals of Surgical Oncology, 24, 3683-3691. https://doi.org/10.1245/s10434-017-6078-x |
| [8] | Kwee, R.M. and Kwee, T.C. (2007) Imaging in Local Staging of Gastric Cancer: A Systematic Review. Journal of Clinical Oncology, 25, 2107-2116. https://doi.org/10.1200/JCO.2006.09.5224 |
| [9] | 郑冬, 田嘉禾. PET/CT在胃癌术前诊断分期中的应用价值综述[J]. 临床医药文献电子杂志, 2017, 4(76): 15043-15044. |
| [10] | 朱娅华, 邓玮玮, 范敏, 郑文璐, 张春银. (18)F-FDG PET/CT显像在胃癌分期及治疗方案制定中的应用价值[J].国际放射医学核医学杂志, 2018, 42(1): 15-20. |
| [11] | Jacquet, P., Jelinek, J.S., Steves, M.A. and Sugarbaker, P.H. (1993) Evaluation of Computed Tomography in Patients with Peritoneal Carcinomatosis. Cancer, 72, 1631-1636.
https://doi.org/10.1002/1097-0142(19930901)72:5<1631::AID-CNCR2820720523>3.0.CO;2-I |
| [12] | Sah, B.R., Owczarczyk, K., Siddique, M., Cook, G.J.R. and Goh, V. (2019) Radiomics in Esophageal and Gastric Cancer. Ab-dominal Radiology (NY), 44, 2048-2058. https://doi.org/10.1007/s00261-018-1724-8 |
| [13] | Sharkey, A.R., Sah, B.R., Withey, S.J., Bhuva, S., Neji, R., Jeljeli, S., Green, A., Cook, G.J.R., Goh, V. and Guy’s & St Thomas’ Oesoph-ago-Gastric Research Group (2021) Initial Experience in Staging Primary Oesophageal/Gastro- Oesophageal Cancer with 18F-FDG PET/MRI. European Journal of Hybrid Imaging, 5, 23.
https://doi.org/10.1186/s41824-021-00117-y |
| [14] | Liu, Y., Zheng, D., Liu, J.J., Cui, J.X., Xi, H.Q., Zhang, K.C., Huang, X.H., Wei, B., Wang, X.X., Xu, B.X., Li, K., Gao, Y.H., Liang, W.Q., Tian, J.H. and Chen, L. (2019) Compar-ing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer. Gastroenterology Research and Practice, 2019, Article ID: 9564627.
https://doi.org/10.1155/2019/9564627 |
| [15] | Muntean, V., Mihailov, A., Iancu, C., Toganel, R., Fabian, O., Domsa, I. and Muntean, M.V. (2009) Staging Laparoscopy in Gastric Cancer. Accuracy and Impact on Therapy. Journal of Gas-trointestinal and Liver Diseases, 18, 189-195. |
| [16] | Chung, H.W., Kim, J.H., Sung, I.K., Lee, S.Y., Park, H.S., Shim, C.S., Bang, H.Y., So, Y. and Lee, E.J. (2019) FDG PET/CT to Predict the Curability of Endoscopic Resection for Early Gastric Cancer. Journal of Cancer Research and Clinical Oncology, 145, 759-764. https://doi.org/10.1007/s00432-018-02832-9 |
| [17] | Kwee, R.M. and Kwee, T.C. (2009) Imaging in Assessing Lymph Node Status in Gastric Cancer. Gastric Cancer, 12, 6-22. https://doi.org/10.1007/s10120-008-0492-5 |
| [18] | Duchon, R., Bernadic, M. and Pindak, D. (2020) Impact of the Anatomical Location and the Number of Metastatic Lymph Nodes on Gastric Cancer Patient’s Survival. Bratislavske Le-karske Listy, 121, 253-258.
https://doi.org/10.4149/BLL_2020_038 |
| [19] | Sano, T., Coit, D.G., Kim, H.H., Roviello, F., Kassab, P., Wittekind, C., Yamamoto, Y. and Ohashi, Y. (2017) Proposal of a New Stage Grouping of Gastric Cancer for TNM Classification: International Gastric Cancer Association Staging Project. Gastric Cancer, 20, 217-225. https://doi.org/10.1007/s10120-016-0601-9 |
| [20] | Oliveira, C., Pinheiro, H., Figueiredo, J., Seruca, R. and Carneiro, F. (2015) Familial Gastric Cancer: Genetic Susceptibility, Pathology, and Implications for Management. The Lancet On-cology, 16, e60-e70.
https://doi.org/10.1016/S1470-2045(14)71016-2 |
| [21] | Ma, D.W., Kim, J.H., Jeon, T.J., Lee, Y.C., Yun, M., Youn, Y.H., Park, H. and Lee, S.I. (2013) 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for the Evaluation of Bone Metastasis in Patients with Gastric Cancer. Digestive and Liver Disease, 45, 769-775. https://doi.org/10.1016/j.dld.2013.02.009 |
| [22] | Korenaga, T.K. and Tewari, K.S. (2020) Gynecologic Cancer in Pregnancy. Gynecologic Oncology, 157, 799-809.
https://doi.org/10.1016/j.ygyno.2020.03.015 |
| [23] | Kinkel, K., Lu, Y., Both, M., Warren, R.S. and Thoeni, R.F. (2002) Detection of Hepatic Metastases from Cancers of the Gastrointestinal Tract by Using Noninvasive Imaging Methods (US, CT, MR Imaging, PET): A Meta-Analysis. Radiology, 224, 748-756. https://doi.org/10.1148/radiol.2243011362 |
| [24] | Lee, J.W., Jo, K., Cho, A., Noh, S.H., Lee, J.D. and Yun, M. (2015) Relationship between 18F-FDG Uptake on PET and Recurrence Patterns after Curative Surgical Resection in Pa-tients with Advanced Gastric Cancer. Journal of Nuclear Medicine, 56, 1494-500. https://doi.org/10.2967/jnumed.115.160580 |
| [25] | 徐鑫, 邓胜明, 李继会, 张玮. (18)F-FDG PET/CT在胃癌分期、复发检测及预后评估中的应用价值[J]. 国际放射医学核医学杂志, 2018, 42(6): 541-546. |
| [26] | 董文婷, 李绍洁, 侯琛琛, 徐辉辉, 郑卫权, 刘岩. (18)F-FDG PET/CT显像在胃癌分期鉴别及预后评估中的价值研究[J]. 中国医学装备, 2021, 18(4): 83-86. |
| [27] | Kaneko, Y., Murray, W.K., Link, E., Hicks, R.J. and Duong, C. (2015) Improving Pa-tient Selection for 18F-FDG PET Scanning in the Staging of Gastric Cancer. Journal of Nuclear Medicine, 56, 523-529.
https://doi.org/10.2967/jnumed.114.150946 |
| [28] | Na, S.J., Park, J.M., Lee, H.H., Lee, S.H., Song, K.Y., Choi, M.G. and Park, C.H. (2016) Prognostic Value of Metabolic Parameters on Preoperative 18F-Fluorodeoxyglucose Posi-tron Emission Tomography/Computed Tomography in Patients with Stage III Gastric Cancer. Oncotarget, 7, 63968-63980. https://doi.org/10.18632/oncotarget.11574 |
| [29] | Park, S.H., Lim, D.H., Sohn, T.S., Lee, J., Zang, D.Y., Kim, S.T., Kang, J.H., Oh, S.Y., Hwang, I.G., Ji, J.H., Shin, D.B., Yu, J.I., Kim, K.M., An, J.Y., Choi, M.G., Lee, J.H., Kim, S., Hong, J.Y., Park, J.O., Park, Y.S., Lim, H.Y., Bae, J.M., Kang, W.K. and ARTIST 2 Investigators (2021) A Randomized Phase III Trial Comparing Adjuvant Single-Agent S1, S-1 with Oxaliplatin, and Postoperative Chemora-diation with S-1 and Oxaliplatin in Patients with Node-Positive Gastric Cancer after D2 Resection: The ARTIST 2 Trial. Annals of Oncology, 32, 368-374.
https://doi.org/10.1016/j.annonc.2020.11.017 |
| [30] | Ilson, D.H. (2018) Advances in the Treatment of Gastric Cancer. Current Opinion in Gastroenterology, 34, 465-468.
https://doi.org/10.1097/MOG.0000000000000475 |
| [31] | Spiegel, D., Palta, M. and Uronis, H. (2017) Role of Chemotherapy and Radiation Therapy in the Management of Gastric Adenocarcinoma. Surgical Clinics of North America, 97, 421-435. https://doi.org/10.1016/j.suc.2016.11.013 |
| [32] | Wu, C.X. and Zhu, Z.H. (2014) Diagnosis and Evalu-ation of Gastric Cancer by Positron Emission Tomography. World Journal of Gastroenterology, 20, 4574-4585. https://doi.org/10.3748/wjg.v20.i16.4574 |
| [33] | Bosch, K.D., Chicklore, S., Cook, G.J., Davies, A.R., Kelly, M., Gossage, J.A. and Baker, C.R. (2020) Staging FDG PET-CT Changes Management in Patients with Gastric Adenocar-cinoma Who Are Eligible for Radical Treatment. European Journal of Nuclear Medicine and Molecular Imaging, 47, 759-767.
https://doi.org/10.1007/s00259-019-04429-x |
| [34] | Giuffrida, M., Viani, L., Iapichino, G.G., Cozzani, F., Dell’Abate, P. and Del Rio, P. (2021) The Metastatic Lymph Node Ratio Is a Better Prognostic Factor than the Number of Metastatic Limph Node after Curative Resection for Gastric Cancer. Acta Biomedica, 92, e2021284. |
| [35] | D？biec, K., Wydmański, J., Gorczewska, I., Leszczyńska, P., Gorczewski, K., Leszczyński, W., d’Amico, A. and Kalemba, M. (2017) 18-Fluorodeoxy-Glucose Positron Emission Tomography-Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy. The Asian Pacific Journal of Cancer Prevention, 18, 2989-2998. |
| [36] | 王志聪, 饶圣祥. 胃癌CT体积测量在预测其术后病理分期中的应用[J]. 放射学实践, 2019, 34(10): 1122-1127. |
